A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical oncology group study JCOG1910 (AgedGlio-PIII)

BACKGROUND: The current standard treatment for elderly patients with newly diagnosed glioblastoma is surgery followed by short-course radiotherapy with temozolomide. In recent studies, 40 Gy in 15 fractions vs. 60 Gy in 30 fractions, 34 Gy in 10 fractions vs. 60 Gy in 30 fractions, and 40 Gy in 15 f...

Descripción completa

Detalles Bibliográficos
Autores principales: Arakawa, Yoshiki, Sasaki, Keita, Mineharu, Yohei, Uto, Megumi, Mizowaki, Takashi, Mizusawa, Junki, Sekino, Yuta, Ono, Tomohiro, Aoyama, Hidefumi, Satomi, Kaishi, Ichimura, Koichi, Kinoshita, Manabu, Ohno, Makoto, Ito, Yoshinori, Nishikawa, Ryo, Fukuda, Haruhiko, Nishimura, Yasumasa, Narita, Yoshitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518265/
https://www.ncbi.nlm.nih.gov/pubmed/34654402
http://dx.doi.org/10.1186/s12885-021-08834-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518265/
https://www.ncbi.nlm.nih.gov/pubmed/34654402
http://dx.doi.org/10.1186/s12885-021-08834-0

Ejemplares similares